Concurrent HPV infection as a predictor of HIV acquisition.

1Adjusted for Baseline variables: study arm, high risk behavior (as defined in Table 1 footnote), high risk partner (as defined in Table 1 footnote), positive test for N gonorrhoeae, C trachomatis, Trichomoniasis vaginalis or syphilis, cohabiting with sexual partner, age 25–34 years or >35 years (compared to age ≤24 years), positive serology for HSV-2, no condom use within the prior 3 months (compared to sometimes or always using condoms), and regular partner not circumcised and Time-dependent variables: condom non-use since last visit; new partner since last visit; circumcision status of new partner; incident infection since the last visit with HSV-2, N gonorrhoeae, C trachomatis, Trichomoniasis vaginalis.2Non-oncogenic types defined as types 6, 11, 32, 40, 54, 55, 61, 69, 70, 83, 84, “mix”, and untyped.3Oncogenic types defined as 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73 and 82v.